Pulse Biosciences Inc (PLSE) Q3 2026 Earnings Call Highlights: NanoPulse AF Study Enrollment ...
Pulse Bio (PLSE) Q3 2026 Earnings Call Transcript
Canaccord Genuity Maintains Buy on Pulse Biosciences, Raises Price Target to $74
What Pulse Biosciences (PLSE) Said on Its Q3 Earnings Call
Pulse Biosciences, Inc. Q3 2026 Earnings Call Summary
Pulse Biosciences Presents Six-Month Interim Results from the PRECISE-BTN Multicenter Study at the American Thyroid Association Annual Meeting
Needham Maintains Buy on Pulse Biosciences, Raises Price Target to $64
Pulse Biosciences Presents Six-Month Interim Results From PRECISE-BTN Thyroid Nodule Study, At 95th ATA Annual Meeting
Pulse Biosciences, Inc. (PLSE) Q3 2026 Earnings Call Transcript
Pulse Biosciences (NASDAQ:PLSE) Posts Mixed Q3 2026 Results as NANOPULSE-AF Enrollment Completes
Pulse Biosciences Reports Business Updates and Third Quarter 2026 Financial Results
Pulse Biosciences Q3 2026 Earnings Call Transcript
Pulse Biosciences to Present at Stifel 2026 Healthcare Conference
Pulse Biosciences (PLSE) Stock Still Seems Rich Against Book Value
Pulse Biosciences Schedules Third Quarter 2026 Financial Results Conference Call for November 5, 2026
Pulse Biosciences (PLSE) Stock Fair Value Rises After Analyst Target Increases
Pulse Biosciences Announces Commercial and Clinical Partnership with the Clayman Thyroid Center
Pulse Biosciences Partners With Clayman Thyroid Center At Hospital For Endocrine Surgery In Tampa, Florida
Pulse Biosciences' 2027 Trial Readout Crucial to Evaluate New Pulsed Field Ablation Modality, Oppenheimer Says
Oppenheimer Maintains Outperform on Pulse Biosciences, Raises Price Target to $60
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.